Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 20;1203475420930223.
doi: 10.1177/1203475420930223. Online ahead of print.

Patient-Driven Discontinuation of Dupilumab During the COVID-19 Pandemic in Two Academic Hospital Clinics at the University of Toronto

Affiliations

Patient-Driven Discontinuation of Dupilumab During the COVID-19 Pandemic in Two Academic Hospital Clinics at the University of Toronto

Jorge R Georgakopoulos et al. J Cutan Med Surg. .

Abstract

No abstract available

Keywords: COVID-19; dermatology; dupilumab; psoriasis.

Similar articles

See all similar articles

LinkOut - more resources

Feedback